IONIS PHARMACEUTICALS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $943.7 | $705.1 | $787.6 | $587.4 | $810.5 |
| Operating income | -$381.7 | -$475.1 | -$353.7 | -$410.2 | -$30.2 |
| Net income | -$381.4 | -$453.9 | -$366.3 | -$269.7 | -$28.6 |
| Cash Flow Statement | |||||
| Free cash flow | -$320.0 | -$546.2 | -$331.3 | -$290.1 | $18.8 |
| Share repurchases | — | — | — | $0.0 | $0.0 |
Shares outstanding 166.2M · Free float 99.3%
Annual filing data through FY ended December 31, 2025; float as of October 8, 2026.